Edmonton, Alberta — November 4, 2025 — Leads & Copy — Innovotech Inc. (TSX-V: IOT) reported record revenues of $1,267,692 in Q3-2025, including a net income of $92,945, and year-to-date revenues of $3,410,204, driven by increased demand for antimicrobial contract research services, strong analytical services performance from Keystone Labs, and increased product sales.
Craig Milne, CEO, stated the company has been building a foundation for continued growth and making investments to support expansion, and is pleased to see the financial performance reflecting the changes.
Innovotech Inc. is a diversified Canadian technology company with business operations in specialized laboratory services, biotechnology, and intellectual property, managing subsidiary companies, including Innovotech Labs Corporation and Keystone Labs Inc. Innovotech Inc. owns a 60% stake in NouLifeSciences Inc., which holds intellectual property related to antioxidant molecules.
Craig Milne, CEO Innovotech Inc.
+1-604-239-1819 craig.milne@innovotech.ca
Source: Innovotech Inc.
